Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Recruiting 3 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 8 Melanoma 3 Neoplasms 2 Uveal Melanoma 1 Sarcoma 1

Interventions

Radiotherapy 11 pembrolizumab 10 Nivolumab 10 Doxorubicin 10 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Cyclophosphamide 8 Biopsy 7 X-Rays 6 Ipilimumab 6 Radiation 5 Phantoms, Imaging 5 Ifosfamide 5 talimogene laherparepvec 4 cabozantinib 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 tazemetostat 3 selpercatinib 3 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 Temozolomide 3 Etoposide 3 ulixertinib 2 tislelizumab 2 tipifarnib 2 palbociclib 2 larotrectinib 2 ivosidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Dacarbazine × Clear all

NCT04733183 2025-01-27

FLASH

Philogen S.p.A.

Phase 2 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡